BUDA JUICE INC (BUDA)
AMEXConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-09-04
AMEXConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-09-04
QuarterlyIQ Insights · BUDA
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 4 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $7.90 BUDA trades at 36× p/e — 2.1× the 17× p/e peer median. The market is re-rating it beyond its own range; our $2.46 fair value is low-confidence here. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| graham number | 12M | $2.89 | — | — | TTM | high |
| Peer P/E | 12M | $3.70 | 16.8 | 0.22 | TTM | high |
| Peer P/S | 12M | $0.97 | 0.9 | 1.13 | TTM | high |
| residual income | 12M | $2.16 | — | — | TTM | high |
| Peer P/S | 3Y |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Only expensive valuation — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Self-history needs ~20 months of data.
| $1.41 |
| 0.9 |
| 1.65 |
| Hist. CAGR(prov.) |
| medium |
| Peer P/S | 5Y | $1.41 | 0.9 | 1.65 | Hist. CAGR(prov.) | medium |